| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
bluebird bio Inc (STU: BLE)
BLE Technical Analysis
5
| As on 30th Sep 2021 BLE STOCK Price closed @ 16.39 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 30.10 & Strong Sell for SHORT-TERM with Stoploss of 41.40 we also expect STOCK to react on Following IMPORTANT LEVELS. |
BLESTOCK Price
| Open | 16.17 | Change | Price | % |
| High | 16.52 | 1 Day | -0.04 | -0.24 |
| Low | 16.17 | 1 Week | 1.19 | 7.83 |
| Close | 16.39 | 1 Month | 1.39 | 9.27 |
| Volume | 200 | 1 Year | -27.98 | -63.06 |
| 52 Week High 49.68 | 52 Week Low 14.63 | ||||
STU Germany Most Active Stocks
| PF8 | 0.02 | 0.00% |
| PF8 | 0.02 | 0.00% |
| PUB | 0.01 | 0.00% |
| PUB | 0.01 | 0.00% |
| PJM | 0.01 | % |
| PJM | 0.01 | % |
| PJM | 0.01 | % |
| PJM | 0.01 | % |
| WDI | 0.05 | -37.50% |
| WDI | 0.05 | -37.50% |
STU Germany Top Gainers Stocks
STU Germany Top Losers Stocks
| BLE Daily Charts |
BLE Intraday Charts |
Whats New @ Bazaartrend |
BLE Free Analysis |
|
|
BLE Important Levels Intraday
| RESISTANCE | 17.06 |
| RESISTANCE | 16.85 |
| RESISTANCE | 16.71 |
| RESISTANCE | 16.58 |
| SUPPORT | 16.20 |
| SUPPORT | 16.07 |
| SUPPORT | 15.93 |
| SUPPORT | 15.72 |
BLE Forecast December 2024
| 4th UP Forecast | 25.41 |
| 3rd UP Forecast | 22.52 |
| 2nd UP Forecast | 20.73 |
| 1st UP Forecast | 18.94 |
| 1st DOWN Forecast | 13.84 |
| 2nd DOWN Forecast | 12.05 |
| 3rd DOWN Forecast | 10.26 |
| 4th DOWN Forecast | 7.37 |
BLE Weekly Forecast
| 4th UP Forecast | 23.25 |
| 3rd UP Forecast | 21.05 |
| 2nd UP Forecast | 19.69 |
| 1st UP Forecast | 18.33 |
| 1st DOWN Forecast | 14.45 |
| 2nd DOWN Forecast | 13.09 |
| 3rd DOWN Forecast | 11.73 |
| 4th DOWN Forecast | 9.53 |
BLE Forecast2024
| 4th UP Forecast | 85.15 |
| 3rd UP Forecast | 63.1 |
| 2nd UP Forecast | 49.47 |
| 1st UP Forecast | 35.84 |
| 1st DOWN Forecast | -3.06 |
| 2nd DOWN Forecast | -16.69 |
| 3rd DOWN Forecast | -30.32 |
| 4th DOWN Forecast | -52.37 |
bluebird bio Inc ( STU Germany Symbol : BLE )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
BLE Business Profile
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases and cancer. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; LentiGlobin for the treatment of sickle cell disease; and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's product candidates in oncology include Idecabtagene vicleucel and bb21217, which are chimeric antigen receptor T (CAR T) cell product candidates for the treatment of multiple myeloma. It has collaboration and license agreements with Bristol-Myers Squibb, Regeneron Pharmaceuticals, Inc., Novartis Pharma AG, Orchard Therapeutics Limited, Medigene AG, Novo Nordisk A/S, Forty Seven, Inc., Gritstone Oncology, Inc., Magenta Therapeutics, Inc., the Seattle Children's Research Institute, University of North Carolina, and the Fred Hutchinson Cancer Research Center. bluebird bio, Inc. has a strategic alliance with National Resilience, Inc. to research, development, and delivery of cell therapies. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts. Address: 60 Binney Street, Cambridge, MA, United States, 02142
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service